InMode Ltd. Profile Avatar - Palmy Investing

InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internati…
Medical - Devices
IL, Yokne'am [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.05 13.45 13.18
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -138.38 -6.28 -2.64
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.75 9.65 9.39
Cash 3.09 9.12 8.84
Capex -429.16 < 0.005 < 0.005
Free Cash Flow -61.12 0.28 0.73
Revenue -37.17 0.95 1.51
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -5.24 0.80 0.84
Operating Margin -44.25 0.23 0.40
ROA -58.42 0.03 0.06
ROE -58.52 0.03 0.07
ROIC -66.09 0.02 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of INMD is permitted for members.
5 Growth
The "Growth Entry" for the Focus of INMD is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of INMD is permitted for members.
End of INMD's Analysis
CIK: 1742692 CUSIP: M5425M103 ISIN: IL0011595993 LEI: - UEI: -
Secondary Listings
INMD has no secondary listings inside our databases.